Allstate (ALL)
(Delayed Data from NYSE)
$169.18 USD
-2.38 (-1.39%)
Updated May 2, 2024 04:00 PM ET
After-Market: $169.26 +0.08 (0.05%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Allstate (ALL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$184.88 | $209.00 | $146.00 | 7.76% |
Price Target
Based on short-term price targets offered by 16 analysts, the average price target for Allstate comes to $184.88. The forecasts range from a low of $146.00 to a high of $209.00. The average price target represents an increase of 7.76% from the last closing price of $171.56.
Analyst Price Targets (16)
Broker Rating
Allstate currently has an average brokerage recommendation (ABR) of 1.47 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 19 brokerage firms. The current ABR compares to an ABR of 1.47 a month ago based on 19 recommendations.
Of the 19 recommendations deriving the current ABR, 15 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 78.95% and 5.26% of all recommendations. A month ago, Strong Buy made up 78.95%, while Buy represented 5.26%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 14 | 14 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.47 | 1.47 | 1.47 | 1.65 | 1.65 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/19/2024 | Raymond James | Charles G Peters | Strong Buy | Strong Buy |
4/11/2024 | Evercore Partners | David Motemaden | Hold | Hold |
4/10/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Buy | Moderate Buy |
4/8/2024 | Roth Capital Partners | Harry Fong | Strong Buy | Strong Buy |
4/1/2024 | Piper Sandler | Paul Newsome | Strong Buy | Strong Buy |
3/21/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/16/2024 | Dowling & Partners | Brenna C Sullivan | Hold | Strong Buy |
12/15/2023 | BMO Capital Markets | Michael Zaremski | Hold | Hold |
11/2/2023 | William Blair | Adam Klauber | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.47 |
ABR (Last week) | 1.47 |
# of Recs in ABR | 19 |
Average Target Price | $184.88 |
LT Growth Rate | 30.40% |
Industry | Insurance - Property and Casualty |
Industry Rank by ABR | 40 of 252 |
Current Quarter EPS Est: | 1.66 |